CLS B — Clinical Laserthermia Systems AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK143.37m
- SEK118.64m
- SEK17.49m
Annual cashflow statement for Clinical Laserthermia Systems AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | Interim Report | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | — | 0.073 | 0.304 | 0.238 | — |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -66.2 | -68.1 | -66.5 | -57.3 | -33.2 |
| Capital Expenditures | -0.555 | -0.562 | -5.5 | -6.63 | -2.8 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.147 | -0.324 | 0 | 0 | — |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.408 | -0.886 | -5.5 | -6.63 | -2.8 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 85.9 | 48.5 | 76.7 | 71.1 | 35 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19.3 | -20.6 | 4.74 | 7.17 | -0.96 |